In 1990, Dr. Hugh Riordan announced the inception of RECNAC – Research Encompassing Novel Approaches to Cancer – with the intent of discovering underlying causes of cancer and finding ways to treat cancer in a nontoxic fashion.

Now, 19 years later, The Riordan Intravenous Vitamin C (IVC) Protocol for Cancer is well known in the integrative and orthomolecular medicine community and is commonly used as an effective adjunct to conventional oncologic therapy. But many unanswered questions remain:

1. What is the best measure of IVC effectiveness?
2. Should other nutrients be added to the IVC solution?
3. Could alternative rates of infusion improve outcome?
4. What types of cancers respond best to IVC therapy?

In an effort to bring IVC-practicing health professionals together for the first time to address these and many other pressing questions concerning IVC adjunctive therapy for cancer, we are pleased to invite you to attend the 1st Annual Riordan IVC and Cancer Symposium, October 2-4, in Wichita, KS, where you will be counted as an IVC pioneer. The symposium will also serve as an excellent opportunity for interested newcomers to IVC therapy to learn the basics of the Riordan IVC Protocol.

Attendees will also receive a panel of antioxidant serum levels as a part of their attendance fee, with an opportunity to test a wide array of nutrient levels, as part of the Health Hunter/Beat the Odds Health Fair that will be going on simultaneously that weekend at The Center.

Featured Articles:

Roundtable - Intravenous Vitamin C for Treating Cancer Alternative and Complementary Therapies, 15(2): 81-86. Jack Challem (moderator), Michael J. Gonzalez, Thomas Edward Levy, Ron Hunninghake, Vivienne Matalon [ Website ] [ Read Full Text ] Article Provided by Mary Ann Liebert, Inc.